| Symbol | Sector | Firm | Action | Grade | Target | Mkt Cap ▼ | Base | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| LOGI | Technology | Morgan Stanley | Downgrade | Overweight → Equal Weight | — | $15.8B | $132.56 | -2.7% | -3.3% | +0.6% | -0.3% | -0.4% | -1.5% |
| AVAL | Financial Services | JP Morgan | Downgrade | Neutral → Underweight | — | $5.0B | $5.89 | -1.5% | +0.3% | -1.2% | +0.2% | +1.7% | -2.5% |
| TAL | Consumer Defensive | Citigroup | Downgrade | Neutral → Sell | — | $2.0B | $31.07 | -1.0% | -5.9% | +2.0% | -3.3% | -16.9% | -14.0% |
| CRCT | Technology | Morgan Stanley | Downgrade | Overweight → Equal Weight | — | $871M | $34.68 | -2.7% | -7.8% | +6.1% | +0.4% | -2.3% | -0.2% |
| GOTU | Consumer Defensive | Citigroup | Downgrade | Buy → Sell | — | $697M | $16.14 | -0.4% | -9.2% | +10.2% | -3.0% | -12.5% | -8.4% |
| TLRY | Healthcare | CIBC | Downgrade | Outperform → Neutral | — | $464M | $200.50 | -0.7% | -0.8% | -3.7% | -6.2% | +0.8% | -3.6% |
| OCGN | Healthcare | Roth Capital | Downgrade | Buy → Neutral | — | $390M | $6.69 | +3.0% | -5.2% | -3.3% | +2.1% | +4.0% | +0.5% |